| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vascular Biology |
From the Division of Neurobiology, Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, NY.
Correspondence to Costantino Iadecola, MD, Division of Neurobiology, Weill Medical College of Cornell University, 411 East 69th Street; KB410, New York, NY 10021. E-mail coi2001{at}med.cornell.edu
Objective Angiotensin II (Ang II) exerts deleterious effect on the cerebral circulation through production of reactive oxygen species (ROS). However, the enzymatic source of the ROS has not been defined. We tested the hypothesis that Ang II impairs endothelium-dependent responses in the cerebral microcirculation through ROS generated in cerebrovascular cells by the enzyme NADPH oxidase.
Methods and Results Cerebral blood flow (CBF) was monitored by laser Doppler flowmetry in anesthetized mice equipped with a cranial window. Ang II (0.25±0.02 µg/kg per minute for 30 to 45 minutes) attenuated the CBF increase produced by the endothelium-dependent vasodilators acetylcholine (42±5%; P<0.05), bradykinin (53±5%; P<0.05), and A23187 (43±4%; P<0.05), and induced cerebrovascular ROS production, assessed by hydroethidine fluoromicrography. These actions of Ang II were prevented by losartan, by the ROS scavenger Mn(III) tetrakis (4-benzoic acid) porphyrin chloride (100 µmol/L), or by the NADPH oxidase peptide inhibitor gp91ds-tat (1 µmol/L), and were not observed in mice lacking the NADPH oxidase subunit gp91phox (nox-2).
Conclusions Ang II impairs the endothelial regulation of the cerebral microcirculation through AT1 receptor-mediated cerebrovascular oxidative stress. The source of the ROS is a nox-2-containing NADPH oxidase. These effects of Ang II could threaten the cerebral blood supply and contribute to the increased susceptibility to stroke and dementia associated with hypertension.
We investigated the mechanism of the effect of angiotensin II on the increase in cerebral blood flow (CBF) produced by endothelium-dependent vasodilators. We found that the attenuation of endothelium-dependent responses induced by Ang II is mediated by free radicals produced by a NADPH oxidase containing nox-2 as the catalytic subunit.
Key Words: cerebral blood flow gp91phox laser Doppler flowmetry NADPH oxidase reactive oxygen species
This article has been cited by other articles:
![]() |
J. R. Jennings, M. F. Muldoon, J. Price, I. C. Christie, and C. C. Meltzer Cerebrovascular Support for Cognitive Processing in Hypertensive Patients Is Altered by Blood Pressure Treatment Hypertension, July 1, 2008; 52(1): 65 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Iida, M. Iida, M. Takenaka, N. Fukuoka, and S. Dohi Rho-kinase inhibitor and Nicotinamide Adenine Dinucleotide PHosphate oxidase inhibitor prevent impairment of endothelium-dependent cerebral vasodilation by acute cigarette smoking in rats Journal of Renin-Angiotensin-Aldosterone System, June 1, 2008; 9(2): 89 - 94. [Abstract] [PDF] |
||||
![]() |
H. Girouard, A. Lessard, C. Capone, T. A. Milner, and C. Iadecola The neurovascular dysfunction induced by angiotensin II in the mouse neocortex is sexually dimorphic Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H156 - H163. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. I. Schrader, D. A. Kinzenbaw, A. W. Johnson, F. M. Faraci, and S. P. Didion IL-6 Deficiency Protects Against Angiotensin II Induced Endothelial Dysfunction and Hypertrophy Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2576 - 2581. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Girouard, L. Park, J. Anrather, P. Zhou, and C. Iadecola Cerebrovascular Nitrosative Stress Mediates Neurovascular and Endothelial Dysfunction Induced by Angiotensin II Arterioscler. Thromb. Vasc. Biol., February 1, 2007; 27(2): 303 - 309. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kitayama, C. Yi, F. M. Faraci, and D. D. Heistad Modulation of Dilator Responses of Cerebral Arterioles by Extracellular Superoxide Dismutase Stroke, November 1, 2006; 37(11): 2802 - 2806. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |